Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard A Fox

Showing results (31-40 of 158) with videos related to

Pageof 16
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion proteinDominik Rüttinger, Rui Li, Christian H Poehlein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2016
Multispectral Imaging of T and B Cells in Murine Spleen and TumorZipei Feng, Shawn M Jensen, David J Messenheimer, et al.
Clinical & Experimental Metastasis|July 20, 2018
Novel frontiers in detecting cancer metastasisStanley P Leong, Carmen Ballesteros-Merino, Shawn M Jensen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 17, 2003
Immunological monitoring of patients with melanoma after peptide vaccination using soluble peptide/HLA-A2 dimer complexesHong-Ming Hu, Annemieke Dols, Sybren L Meijer, et al.
Cellular Immunology|May 12, 2004
Reduced L-selectin (CD62LLow) expression identifies tumor-specific type 1 T cells from lymph nodes draining an autologous tumor cell vaccineSybren L Meijer, Annemieke Dols, Hong-Ming Hu, et al.
Nature Communications|November 18, 2024
IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cellsOlivier Fesneau, Kimberly A Samson, Wesley Rosales, et al.
Journal of Translational Medicine|March 16, 2007
Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptorHauke Winter, Natasja K van den Engel, Christian H Poehlein, et al.
Plos One|May 24, 2019
Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancerAkiko Suzuki, Sachin Puri, Pamela Leland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2009
Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunityUlf Petrausch, Shawn M Jensen, Christopher Twitty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cellsChristian H Poehlein, Hong-Ming Hu, Jane Yamada, et al.
Pageof 16

Showing results (31-40 of 158) with videos related to

Sort By:
Pageof 16
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion proteinDominik Rüttinger, Rui Li, Christian H Poehlein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2016
Multispectral Imaging of T and B Cells in Murine Spleen and TumorZipei Feng, Shawn M Jensen, David J Messenheimer, et al.
Clinical & Experimental Metastasis|July 20, 2018
Novel frontiers in detecting cancer metastasisStanley P Leong, Carmen Ballesteros-Merino, Shawn M Jensen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 17, 2003
Immunological monitoring of patients with melanoma after peptide vaccination using soluble peptide/HLA-A2 dimer complexesHong-Ming Hu, Annemieke Dols, Sybren L Meijer, et al.
Cellular Immunology|May 12, 2004
Reduced L-selectin (CD62LLow) expression identifies tumor-specific type 1 T cells from lymph nodes draining an autologous tumor cell vaccineSybren L Meijer, Annemieke Dols, Hong-Ming Hu, et al.
Nature Communications|November 18, 2024
IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cellsOlivier Fesneau, Kimberly A Samson, Wesley Rosales, et al.
Journal of Translational Medicine|March 16, 2007
Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptorHauke Winter, Natasja K van den Engel, Christian H Poehlein, et al.
Plos One|May 24, 2019
Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancerAkiko Suzuki, Sachin Puri, Pamela Leland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2009
Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunityUlf Petrausch, Shawn M Jensen, Christopher Twitty, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cellsChristian H Poehlein, Hong-Ming Hu, Jane Yamada, et al.
Pageof 16